Re "in New Zealand and Canada and the approval is for children and adults." Was there a later announcement than this http://www.asx.com.au/asxpdf/20140429/pdf/42p7qg0gyxdn7q.pdf in particular " Prochymal became the world's first stem cell therapy to be approved in Canada and New Zealand as a first-line treatment for SR-aGVHD in children."? Japan is the market that has it approved in both adults and children I believe.
Also, I am not sure of the logic with "Obvious it works other wise they would not have purchased Osiris!" Osiris sold it presumably because they felt they should; it failed to meet end points in NZ and Canada . With regards "Mesoblast has moved on with making changes to there technology."; ok, if they have and it is beneficial I guess we will see in time.
- Forums
- ASX - By Stock
- MSB
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-20
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 75212 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 1.185 |
1 | 20000 | 1.175 |
1 | 5664 | 1.170 |
1 | 17568 | 1.160 |
3 | 56695 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 59712 | 2 |
1.195 | 36255 | 5 |
1.200 | 404381 | 31 |
1.205 | 3000 | 1 |
1.210 | 162475 | 7 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |